ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank88
3Y CAGR+21.2%
5Y CAGR+12.6%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+21.2%/yr
vs +34.2%/yr prior
5Y CAGR
+12.6%/yr
Recent acceleration
Acceleration
-13.0pp
Decelerating
Percentile
P88
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$109.82M-3.7%
2024$114.07M+33.9%
2023$85.17M+38.1%
2022$61.68M+8.5%
2021$56.86M-6.4%
2020$60.76M+166.0%
2019$22.84M+20.1%
2018$19.03M-0.5%
2017$19.13M-